Topic hub · Research Peptides

Research Peptides: BPC-157, GLP-1s and the 2026 Rules

Research peptides are short amino-acid chains such as BPC-157, TB-500 and GHK-Cu sold as laboratory reagents labelled 'research use only', not as approved medicines. This hub covers what the evidence on each peptide shows, the 2026 FDA compounding vote, approved GLP-1 drugs and pipeline candidates, and how to read a peptide certificate of analysis.

Start with the explainers on peptide types and research-use-only labelling, then use the clusters for BPC-157, GLP-1 weight-loss drugs, growth hormone peptides or NAD+. We separate animal data from human trials, cite FDA, PubMed and company trial releases, and date regulatory facts. We do not give dosing or sourcing advice for human use.

Updated 25 October 202621 guidesPrimary sources cited in every articleIndependent, evidence-first

Start here

Essential Research Peptides guides

The six articles we would read first: the basics, the law, safety and how to judge a product.

Key facts, 25 October 2026

Research Peptides at a glance

FDA approval

None for BPC-157 or TB-500

Peptides sold as 'research use only' are not approved or intended for human or veterinary use.

503A compounding vote

Advisers backed 6 of 7

FDA panel, 23–24 July 2026. Non-binding; nothing added to the bulks list yet and rulemaking is required.

Oral GLP-1s

Two pills FDA-approved

Foundayo (orforglipron) and the Wegovy pill; self-pay roughly $149–$299 a month (Ro, August 2026).

Retatrutide

Unapproved; filing planned 2027

Lilly reported further positive Phase 3 TRIUMPH results and plans an FDA submission in the first quarter of 2027.

Research peptide rules and labelling

What 'research use only' means, how the 503A bulks list works and what FDA's 2026 advisory vote changed.

GLP-1 and weight-loss peptides

Approved GLP-1 drugs and pipeline candidates compared on trial data, safety and legal status.

BPC-157 and recovery peptides

BPC-157, TB-500 and GHK-Cu: the animal evidence, the thin human data and the safety unknowns.

Growth hormone and nootropic peptides

Ipamorelin, CJC-1295, sermorelin, Selank and Semax compared on mechanism, evidence and regulatory status.

NAD+ and its precursors

What the evidence supports for NAD+ drips and injections, and how NR, NMN and niacin compare.

Lab testing and suppliers

How to read peptide purity, identity and endotoxin results, and how suppliers compare on documentation.

Newest first

Latest Research Peptides articles

Questions

Research Peptides: frequently asked questions

What are research peptides?

Research peptides are short chains of amino acids, such as BPC-157, TB-500 and GHK-Cu, sold as laboratory reagents labelled 'research use only', meaning not for human or veterinary use. They are not FDA-approved drugs, and the label does not mean a product has been tested for safety in people or made to pharmaceutical standards.

Is BPC-157 legal?

BPC-157 is not FDA-approved for any use and is not on the 503A bulks list, so it cannot currently be routinely compounded. In July 2026 an FDA advisory committee voted 8 to 6 to recommend adding it, but the vote is non-binding and rulemaking with a public comment period would come first. It is sold only as a research chemical.

What did the FDA peptide advisory vote decide?

On 23 and 24 July 2026 FDA's Pharmacy Compounding Advisory Committee reviewed seven peptides. It recommended adding BPC-157, KPV, TB-500, MOTS-c, Semax and Epitalon to the 503A bulks list and rejected emideltide (DSIP). FDA staff had recommended against all seven, and nothing has been added to the list yet.

Are there GLP-1 pills for weight loss?

Yes. Foundayo (orforglipron) from Lilly and the Wegovy pill (oral semaglutide) from Novo Nordisk are FDA-approved. Self-pay prices listed by Ro in August 2026 ranged from roughly $149 to $299 a month depending on the product and strength. Retatrutide, a triple agonist, remains unapproved, with an FDA filing planned for early 2027.

How can I tell if a research peptide is pure?

Ask for a batch-specific certificate of analysis from an independent lab showing HPLC purity, mass spectrometry confirming the expected molecular weight, and ideally endotoxin results. Check that the batch number matches the vial and that the report is dated. Purity testing confirms what is in the vial; it does not make a peptide safe for human use.

Keep exploring

Related topic hubs

Research a brand

Check a brand before you buy

Our directory lists brands with public, batch-level lab reports. A listing is not an endorsement, and editorial coverage is independent of paid placements.

How we work: every article cites primary sources (peer-reviewed studies, FDA and DEA documents, the Federal Register and state law), says where the evidence is thin, and is dated so you can see when the legal picture was last checked. Nothing here is medical or legal advice. Read our editorial policy.

Scroll to Top

Disclaimer: Alternative Pharm Press is an independent editorial publication and brand directory; we do not sell, manufacture, or ship any products. The statements and products referenced on this site have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Content is provided for general informational and educational purposes only and is not medical, legal, or professional advice. Always consult a licensed healthcare provider before using kratom, cannabis, CBD, hemp, nootropic, peptide, or any related product, especially if you are under 21, pregnant or nursing, taking medication, or managing a health condition. The legal status of these products varies by country, state, and locality; you are solely responsible for verifying and complying with the laws that apply to you. Some listings, reviews, and coupons may be paid placements or affiliate relationships, which do not influence our editorial standards.